Innoviva (INVA) EPS (Basic) (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,328.64% |
| Dec 31, 2025 | -115.78% |
| Sep 30, 2025 | 28.71% |
| Jun 30, 2025 | 236.49% |
| Mar 31, 2025 | -340.43% |
| Dec 31, 2024 | -940.08% |
| Sep 30, 2024 | 103.64% |
| Jun 30, 2024 | -194.83% |
| Mar 31, 2024 | 676.96% |
| Dec 31, 2023 | -107.98% |
| Sep 30, 2023 | 6,200.00% |
| Jun 30, 2023 | -96.08% |
| Mar 31, 2023 | 443.90% |
| Dec 31, 2022 | -103.89% |
| Sep 30, 2022 | 38,000.00% |
| Jun 30, 2022 | -95.65% |
| Mar 31, 2022 | 412.07% |
| Dec 31, 2021 | -107.09% |
| Sep 30, 2021 | 2.97% |
| Jun 30, 2021 | 8.60% |
| Mar 31, 2021 | 75.47% |
| Dec 31, 2020 | 89.29% |
| Sep 30, 2020 | -63.16% |
| Jun 30, 2020 | 16.92% |
| Mar 31, 2020 | 44.44% |
| Dec 31, 2019 | 15.38% |
| Sep 30, 2019 | 5.41% |
| Jun 30, 2019 | 12.12% |
| Mar 31, 2019 | -87.36% |
| Dec 31, 2018 | 455.32% |
| Sep 30, 2018 | -12.96% |
| Jun 30, 2018 | 86.21% |
| Mar 31, 2018 | -47.27% |
| Dec 31, 2017 | 150.00% |
| Sep 30, 2017 | -33.33% |
| Jun 30, 2017 | 106.25% |
| Mar 31, 2017 | -33.33% |
| Dec 31, 2016 | 71.43% |
| Sep 30, 2016 | 7.69% |
| Jun 30, 2016 | 225.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 200.00% |
| Sep 30, 2015 | 42.86% |
| Jun 30, 2015 | 22.22% |
| Mar 31, 2015 | 35.71% |
| Dec 31, 2014 | 26.32% |
| Sep 30, 2014 | -5.56% |
| Jun 30, 2014 | -20.00% |
| Mar 31, 2014 | 67.39% |
| Dec 31, 2013 | -411.11% |
| Sep 30, 2013 | 75.68% |
| Jun 30, 2013 | -236.36% |
| Mar 31, 2013 | 67.65% |
| Dec 31, 2012 | 8.11% |
| Sep 30, 2012 | 11.90% |
| Jun 30, 2012 | -141.58% |
| Mar 31, 2012 | 324.44% |
| Dec 31, 2011 | -21.62% |
| Sep 30, 2011 | -19.35% |
| Jun 30, 2011 | -10.71% |
| Mar 31, 2011 | -12.00% |
| Dec 31, 2010 | 13.79% |
| Sep 30, 2010 | -3.57% |